JP2019205792A - Intracutaneous injection aid - Google Patents

Intracutaneous injection aid Download PDF

Info

Publication number
JP2019205792A
JP2019205792A JP2018103795A JP2018103795A JP2019205792A JP 2019205792 A JP2019205792 A JP 2019205792A JP 2018103795 A JP2018103795 A JP 2018103795A JP 2018103795 A JP2018103795 A JP 2018103795A JP 2019205792 A JP2019205792 A JP 2019205792A
Authority
JP
Japan
Prior art keywords
injection needle
angle
skin
injection
puncture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018103795A
Other languages
Japanese (ja)
Inventor
雅也 梅▲崎▼
Masaya Umezaki
雅也 梅▲崎▼
健介 谷口
Kensuke Taniguchi
健介 谷口
堀田 泰治
Taiji Hotta
泰治 堀田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisei Kako Co Ltd
Original Assignee
Taisei Kako Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisei Kako Co Ltd filed Critical Taisei Kako Co Ltd
Priority to JP2018103795A priority Critical patent/JP2019205792A/en
Publication of JP2019205792A publication Critical patent/JP2019205792A/en
Pending legal-status Critical Current

Links

Images

Abstract

To provide an intracutaneous injection aid that allows an injection needle to be stuck into the skin easily and accurately.SOLUTION: An intracutaneous injection aid 1 includes: a holding part 3 for holding an injection needle 2; and a stretching part 4 to be pressed against the surface of the skin to stretch the skin, which is disposed at a position separated from the tip of the injection needle 2 by a predetermined distance in a direction along a center line of the injection needle 2 on a virtual plane that includes the center line of the injection needle and spreads in a lateral width direction of the intracutaneous injection aid 1. The stretching part 4 includes a stretching surface whose inclination angle with respect to the virtual plane is set to an angle in a range from a minimum angle to a maximum angle of the sticking angle of the injection needle 2.SELECTED DRAWING: Figure 2

Description

本発明は、皮内注射を補助するための皮内注射用補助具に関する。   The present invention relates to an auxiliary device for intradermal injection for assisting intradermal injection.

従来から、上記の皮内注射用補助具には種々のものが提案されている。例えば、特許文献1に開示されている皮内注射用補助具(皮内注射用のアダプタ)は、筒状であり且つ後端側から注射器を抜差可能なアダプタ本体部と、該アダプタ本体部の先端側に設けられた遠位部であって、皮膚を伸展させるための遠位部と、を備えたものである。   Conventionally, various types of auxiliary devices for intradermal injection have been proposed. For example, an auxiliary device for intracutaneous injection (adapter for intradermal injection) disclosed in Patent Document 1 is an adapter main body that is cylindrical and can be inserted and removed from the rear end side, and the adapter main body And a distal portion for extending the skin.

アダプタ本体部は、内部に差し込まれた注射器を軸線方向でスライドさせることができるように構成されている。   The adapter main body is configured so that the syringe inserted therein can be slid in the axial direction.

遠位部は、皮膚に押し付けられる皮膚接触主面であって、鈍角に屈曲した形状の皮膚接触主面を有する。より具体的に説明すると、皮膚接触主面には、アダプタ本体部の先端側の開口を遮るように形成された第一の皮膚接触主面と、該第一の皮膚接触主面からアダプタ本体部の軸線方向に沿って前方に延出する平坦な第二の皮膚接触主面とが含まれており、該第一の皮膚接触主面には、アダプタ本体部内に差し込まれた注射器の注射針(穿刺針)を出退可能な針用開口部が形成されている。   The distal portion is a skin contact main surface that is pressed against the skin, and has a skin contact main surface that is bent at an obtuse angle. More specifically, the skin contact main surface includes a first skin contact main surface formed so as to block the opening on the distal end side of the adapter main body, and the adapter main body portion from the first skin contact main surface. A flat second skin contact main surface extending forward along the axial direction of the first skin contact main surface, and the first skin contact main surface includes a syringe needle (injected into the adapter body) ( A needle opening through which the puncture needle can be withdrawn and withdrawn is formed.

かかる皮内注射用のアダプタを用いて皮内注射を行う場合は、第一の皮膚接触主面で皮膚の一部を沈み込ませて伸展させ、さらに、第二の皮膚接触面を皮膚に当接させることでアダプタ本体部及び注射器の姿勢を皮膚表面(第二の皮膚接触面が当接している皮膚表面)に対して水平若しくは略水平にする。   When intradermal injection is performed using such an adapter for intradermal injection, a part of the skin is submerged and extended on the first skin contact main surface, and the second skin contact surface is applied to the skin. By making contact, the posture of the adapter main body and the syringe is made horizontal or substantially horizontal with respect to the skin surface (the skin surface with which the second skin contact surface is in contact).

そして、アダプタ本体部内で注射器を前進させると、穿刺針が針用開口から外部に進出し、これにより、皮膚表面に対して水平若しくは略水平な姿勢の穿刺針が伸展した皮膚に刺さる。   Then, when the syringe is advanced in the adapter main body, the puncture needle advances from the needle opening to the outside, whereby the puncture needle in a posture that is horizontal or substantially horizontal with respect to the skin surface is stuck into the extended skin.

このように、前記皮内注射用のアダプタは、遠位部で皮膚を伸展させ且つ穿刺針の向きを定めた後に穿刺針を皮膚に刺すように構成されている。   Thus, the adapter for intradermal injection is configured to pierce the skin with the puncture needle after extending the skin at the distal portion and determining the direction of the puncture needle.

特許第5213950号公報Japanese Patent No. 5213950

ところで、上記従来の皮内注射用のアダプタでは、第一の皮膚接触主面を皮膚に押し付けて皮膚を伸展させ且つ第二の皮膚接触主面を皮膚に当接させて注射器(穿刺針)の向きを定めた後に、第一の皮膚接触主面を皮膚に押し付けた状態を維持しながら穿刺針を皮膚に刺す必要があるが、第一の皮膚接触主面を皮膚に押し付けてから穿刺針を皮膚に刺すまでの間にアダプタが動いてしまい、穿刺針の穿刺位置や穿刺角度がずれてしまうことがある。   By the way, in the conventional adapter for intradermal injection, the first skin contact main surface is pressed against the skin to extend the skin, and the second skin contact main surface is brought into contact with the skin, so that the syringe (puncture needle) After the orientation is determined, it is necessary to puncture the skin with the puncture needle while maintaining the state where the first skin contact main surface is pressed against the skin. The adapter may move before the skin is stabbed, and the puncture position and puncture angle of the puncture needle may be shifted.

また、上記従来の皮内注射用のアダプタでは、第一の皮膚接触主面を皮膚に押し付ける操作、すなわち、皮膚を伸展させるための操作と、穿刺針を皮膚に刺すための操作とを別々に行う必要があるため、皮内注射を実施する手順が煩雑になる。   In the conventional adapter for intradermal injection, the operation for pressing the first skin contact main surface against the skin, that is, the operation for extending the skin and the operation for inserting the puncture needle into the skin are performed separately. Since it is necessary to carry out, the procedure which performs intradermal injection becomes complicated.

このように、上記従来の皮内注射用のアダプタを用いた皮内注射では、穿刺針を皮膚に対して正確に刺すことが難しく、また、穿刺針を皮膚に刺すまでの手順が煩雑なものであった。   As described above, in the intradermal injection using the conventional adapter for intradermal injection, it is difficult to accurately puncture the puncture needle into the skin, and the procedure until the puncture needle is inserted into the skin is complicated. Met.

そこで、本発明は、かかる実情に鑑み、皮内注射を行う際に皮膚に対して注射針を容易且つ正確に穿刺できる皮内注射用補助具を提供することを課題とする。   Then, this invention makes it a subject to provide the auxiliary tool for intradermal injection which can puncture an injection needle easily and correctly with respect to skin when performing intradermal injection in view of this situation.

本発明の皮内注射用補助具は、
注射針を保持する保持部と、
皮膚の表面に押し付けて皮膚を伸展させる伸展部であって、前記注射針の中心線を含み且つ横幅方向に広がる仮想平面上において、該中心線に沿う方向で前記注射針の先端から所定距離だけ離間した位置に配置される伸展部と、を備え、
前記伸展部は、前記仮想平面に対する傾斜角度が前記注射針の穿刺角度の最小角度から最大角度までの範囲内の角度に設定される伸展面を有する。
Auxiliary device for intradermal injection of the present invention,
A holding part for holding the injection needle;
An extension part that presses against the surface of the skin and extends the skin, and includes a center line of the injection needle and extends in a lateral width direction, and extends a predetermined distance from the tip of the injection needle in a direction along the center line. An extending portion disposed at a spaced position;
The extension portion has an extension surface in which an inclination angle with respect to the virtual plane is set to an angle within a range from a minimum angle to a maximum angle of the puncture angle of the injection needle.

上記構成の皮内注射用補助具によれば、前記仮想平面に対する伸展面の傾斜角度が、注射針の穿刺角度の範囲内の角度に設定されるため、伸展面を皮膚に当接させると、注射針が穿刺角度の範囲内で皮膚に対して傾く。   According to the intradermal injection aid of the above configuration, since the inclination angle of the extension surface with respect to the virtual plane is set to an angle within the range of the puncture angle of the injection needle, when the extension surface is brought into contact with the skin, The injection needle is tilted with respect to the skin within the range of the puncture angle.

そして、伸展部を前方に移動させながら伸展面で皮膚を押し込むと、注射針の先端と伸展部との間の皮膚が伸展されるとともに、注射針が傾き(皮膚に対する傾き)を保ったまま皮膚に刺さる。   Then, when the skin is pushed in with the extension surface while moving the extension part forward, the skin between the tip of the injection needle and the extension part is extended, and the injection needle keeps the inclination (inclination with respect to the skin). Bite.

このように、上記構成の皮内注射用補助具は、皮膚を伸展させる操作の流れの中で、注射針を穿刺角度の最小角度から最大角度までの範囲内の角度で傾けたまま皮膚に刺すことができる。   As described above, the intradermal injection assist device having the above-described configuration is inserted into the skin while the injection needle is inclined at an angle within the range from the minimum angle to the maximum angle of the puncture angle in the flow of the operation for extending the skin. be able to.

本発明の皮内注射用補助具は、
前記仮想平面上であり且つ前記横幅方向における前記注射針の両側に配置される一対の保護部を備えていてもよい。
Auxiliary device for intradermal injection of the present invention,
You may provide a pair of protection part arrange | positioned on the said virtual plane, and the both sides of the said injection needle in the said width direction.

かかる構成によれば、前記仮想平面上における注射針の前方には伸展部が配置され、注射針の両側には保護部が配置されるため、注射針の周囲が伸展部と保護部とで囲まれる。従って、上記構成の皮内注射用補助具は、注射針が不用意に人体等に接触してしまうことを抑制でき、また、注射針が誤った姿勢で皮膚に刺さってしまうことを防止できる。   According to such a configuration, since the extension portion is disposed in front of the injection needle on the virtual plane and the protection portions are disposed on both sides of the injection needle, the periphery of the injection needle is surrounded by the extension portion and the protection portion. It is. Therefore, the auxiliary tool for intradermal injection configured as described above can prevent the injection needle from inadvertently coming into contact with the human body or the like, and can prevent the injection needle from being stuck in the skin in an incorrect posture.

さらに、本発明の皮内注射用補助具において、
前記保護部は、前記横幅方向で前記注射針との間に間隔をあけて配置されていてもよい。
Furthermore, in the auxiliary device for intradermal injection of the present invention,
The protective part may be arranged with a space between the injection needle in the lateral width direction.

皮内注射では、真皮への注射液の注入に伴って皮膚の表面が部分的に膨らんで膨隆部となるが、上記構成の皮内注射用補助具によれば、注射針と該注射針の周囲に配置されている伸展部や保護部との間にスペースが形成されるため、膨隆部の形成、すなわち、真皮への注射液の注入が妨げられにくくなる。   In the case of intradermal injection, the surface of the skin partially swells and becomes a bulging portion as the injection solution is injected into the dermis. According to the intradermal injection aid having the above structure, the injection needle and the injection needle Since a space is formed between the extension part and the protection part arranged around, the formation of the bulge part, that is, the injection of the injection solution into the dermis is hardly hindered.

本発明の皮内注射用補助具において、
前記保持部の先端部側の下面には、前記保持部の後端部側の下面よりも下方側に膨出する深刺抑制部が形成されていてもよい。
In the auxiliary device for intradermal injection of the present invention,
A deep puncture suppressing portion that bulges further downward than a lower surface on the rear end portion side of the holding portion may be formed on the lower surface on the front end portion side of the holding portion.

かかる構成によれば、保持部の先端部側の下面には、後端部側の下面よりも下方側に膨出する深刺抑制部が形成されるため、伸展面を皮膚に押し込む際に、該深刺抑制部が皮膚に当接したことを目安にして伸展面を押し込む操作、すなわち、皮膚に注射針を刺し込む操作を止めることができる。従って、上記構成の皮内注射用補助具は、注射針が皮膚に対して過剰に刺し込まれてしまうことを抑制できる。   According to such a configuration, since the deep puncture suppressing portion that bulges downward from the lower surface on the rear end portion side is formed on the lower surface on the front end portion side of the holding portion, when pushing the extension surface into the skin, It is possible to stop the operation of pushing the extension surface, that is, the operation of inserting the injection needle into the skin with reference to the deep puncture suppression unit being in contact with the skin. Therefore, the auxiliary tool for intradermal injection having the above-described configuration can prevent the injection needle from being excessively inserted into the skin.

この場合、前記深刺抑制部の下面には、前記仮想平面に対する傾斜角度が前記注射針の穿刺角度の最小角度から最大角度までの範囲内の角度に設定される角度制限面が含まれていてもよい。   In this case, the lower surface of the deep puncture suppressing portion includes an angle limiting surface in which an inclination angle with respect to the virtual plane is set to an angle within a range from a minimum angle to a maximum angle of the puncture angle of the injection needle. Also good.

かかる構成によれば、誤って伸展部を皮膚に当接させずに注射針を皮膚に穿刺してしまった場合であっても、保持部の外底部に形成された角度制限面が皮膚に当接すれば、注射針が穿刺角度の最小角度から最大角度までの範囲内の角度で傾くため、使用手順を誤った場合であっても、注射針の穿刺角度が許容範囲を超えてしまうことを抑制できる。   According to this configuration, even if the injection needle is punctured into the skin without accidentally bringing the extension portion into contact with the skin, the angle limiting surface formed on the outer bottom portion of the holding portion contacts the skin. If it comes in contact, the injection needle tilts at an angle within the range from the minimum angle to the maximum angle of the puncture angle, so the puncture angle of the injection needle is prevented from exceeding the allowable range even if the usage procedure is incorrect. it can.

本発明の皮内注射用補助具において、
前記保護部の下面は、上方側に向かって凸状に湾曲する逃面となっていてもよい。
In the auxiliary device for intradermal injection of the present invention,
The lower surface of the protection part may be a relief surface that curves in a convex shape toward the upper side.

かかる構成によれば、保護部によって皮膚が圧迫されにくくなるため、真皮に注射液を注入する際に、膨隆部の形成を阻害しないようにすることができる(すなわち、真皮への注射液の注入を阻害しないようにすることができる)。   According to such a configuration, since the skin is not easily pressed by the protective portion, it is possible to prevent the formation of the bulging portion when the injection solution is injected into the dermis (that is, injection of the injection solution into the dermis). Can not be disturbed).

以上のように、本発明の皮内注射用補助具は、皮内注射を行う際に皮膚に対して注射針を容易且つ正確に穿刺できる、という優れた効果を奏し得る。   As described above, the auxiliary device for intradermal injection of the present invention can provide an excellent effect that an injection needle can be punctured easily and accurately into the skin when performing intradermal injection.

図1は、本発明の一実施形態に係る皮内注射用補助具の斜視図である。FIG. 1 is a perspective view of an intradermal injection aid according to an embodiment of the present invention. 図2は、同実施形態に係る皮内注射用補助具の平面図である。FIG. 2 is a plan view of the auxiliary tool for intradermal injection according to the embodiment. 図3は、同実施形態に係る皮内注射用補助具の側面図である。FIG. 3 is a side view of the auxiliary device for intradermal injection according to the embodiment. 図4は、同実施形態に係る皮内注射用補助具の縦断面図である。FIG. 4 is a longitudinal sectional view of the auxiliary device for intradermal injection according to the embodiment. 図5は、同実施形態に係る皮内注射用補助具の使用状態の説明図であって、(a)は伸展面を皮膚に当接させる際の説明図であり、(b)は伸展させた皮膚に注射針が刺さる直前の説明図である。FIG. 5 is an explanatory view of the use state of the auxiliary device for intradermal injection according to the embodiment, wherein (a) is an explanatory view when the extended surface is brought into contact with the skin, and (b) is extended. It is explanatory drawing just before an injection needle pierces the skin. 図6は、同実施形態に係る皮内注射用補助具の使用状態の説明図であって、(a)は伸展させた皮膚に注射針を刺した状態の説明図であり、(b)は真皮の内側に注射液を注入している状態の説明図である。FIG. 6 is an explanatory view of the use state of the auxiliary tool for intradermal injection according to the embodiment, wherein (a) is an explanatory view of a state where an injection needle is inserted into the extended skin, and (b) It is explanatory drawing of the state which has injected the injection solution inside the dermis. 図7は、本発明の他実施形態に係る皮内注射用補助具の側面図である。FIG. 7 is a side view of an auxiliary device for intradermal injection according to another embodiment of the present invention. 図8は、図7に示す皮内注射用補助具の縦断面図である。8 is a longitudinal sectional view of the auxiliary device for intradermal injection shown in FIG. 図9は、本発明の別の実施形態に係る皮内注射用補助具の側面図である。FIG. 9 is a side view of an auxiliary device for intradermal injection according to another embodiment of the present invention. 図10は、図9に示す皮内注射用補助具の縦断面図である。10 is a longitudinal sectional view of the auxiliary device for intradermal injection shown in FIG.

以下、本発明の一実施形態に係る皮内注射用補助具について添付図面を参照しつつ説明を行う。本実施形態に係る皮内注射用補助具は、皮内注射を行う際に用いるものである。なお、本実施形態では、皮内注射用補助具の横幅に対応する方向を横幅方向、皮内注射用補助具の高さに対応する方向を高さ方向、横幅方向と高さ方向とに直交する方向を前後方向、と称する。   Hereinafter, an auxiliary tool for intradermal injection according to an embodiment of the present invention will be described with reference to the accompanying drawings. The auxiliary device for intradermal injection according to this embodiment is used when performing intradermal injection. In this embodiment, the direction corresponding to the lateral width of the intradermal injection assisting device is the lateral width direction, the direction corresponding to the height of the intradermal injection assisting device is the height direction, and the lateral width direction and the height direction are orthogonal to each other. The direction to do is called the front-back direction.

皮内注射用補助具は、図1に示すように、注射針2を保持する保持部3と、皮膚の表面に押し付けることで皮膚を伸展させる伸展部4であって、前記注射針2の中心線を含み且つ前記横幅方向に広がる仮想平面上において、該中心線に沿って前記注射針2の先端から所定距離だけ離間するように配置される伸展部4と、該伸展部4と前記保持部3とを接続する接続アーム部5とを有する。   As shown in FIG. 1, the auxiliary device for intradermal injection includes a holding portion 3 for holding the injection needle 2 and an extension portion 4 for extending the skin by pressing against the surface of the skin, and the center of the injection needle 2 An extension part 4 arranged so as to be separated from the distal end of the injection needle 2 along the center line by a predetermined distance on a virtual plane including a line and extending in the lateral width direction, the extension part 4 and the holding part 3 and a connecting arm portion 5 for connecting the three.

保持部3は、図4に示すように、注射器6が取り付けられる注射器用取付部30と、該注射器用取付部30に設けられ且つ注射針2が取り付けられる注射針用取付部31と、注射針用取付部31の周囲に広がるベース部32(図2参照)と、を有する。   As shown in FIG. 4, the holding part 3 includes a syringe attachment part 30 to which the syringe 6 is attached, a syringe needle attachment part 31 that is provided in the syringe attachment part 30 and to which the injection needle 2 is attached, and a syringe needle. And a base portion 32 (see FIG. 2) extending around the mounting portion 31 for use.

注射器用取付部30には、注射器6のノズル60を挿入可能である。より具体的に説明すると、注射器用取付部30は、筒状のノズル挿入部300と、ノズル挿入部300の軸線方向における後端側の外面から径方向外方に向かって突出する突出部301と、を有する。   The nozzle 60 of the syringe 6 can be inserted into the mounting portion 30 for the syringe. More specifically, the syringe attachment portion 30 includes a cylindrical nozzle insertion portion 300, and a protrusion 301 protruding radially outward from the outer surface on the rear end side in the axial direction of the nozzle insertion portion 300. Have.

ノズル挿入部300の内周面は、後端側から先端側になるにつれて内径が徐々に小さくなるようにテーパー状に形成されていてもよい。   The inner peripheral surface of the nozzle insertion portion 300 may be formed in a tapered shape so that the inner diameter gradually decreases from the rear end side to the front end side.

突出部301は、ノズル挿入部300の外周面に対して、周方向(ノズル挿入部300の外周面の周方向)で間隔をあけて複数設けられている。本実施形態では、2つの突出部301がノズル挿入部300の外周面に設けられているが、突出部301の数は、1つであっても3つ以上であってもよい。   A plurality of protrusions 301 are provided with a gap in the circumferential direction (the circumferential direction of the outer circumferential surface of the nozzle insertion portion 300) with respect to the outer circumferential surface of the nozzle insertion portion 300. In the present embodiment, the two protrusions 301 are provided on the outer peripheral surface of the nozzle insertion part 300, but the number of the protrusions 301 may be one or three or more.

注射針用取付部31は、注射器用取付部30の先端側の開口を塞ぐように形成されている。また、注射針用取付部31は、注射器用取付部30の先端から延出するように形成されており、基端から先端に亘って連続する貫通孔310が形成されており、この貫通孔310に対して注射針2が挿通されている。   The attachment part 31 for injection needles is formed so that the opening of the front end side of the attachment part 30 for syringes may be plugged up. The injection needle attachment portion 31 is formed so as to extend from the distal end of the syringe attachment portion 30, and a through-hole 310 continuous from the proximal end to the distal end is formed. In contrast, the injection needle 2 is inserted.

貫通孔310は、ノズル挿入部300の軸線が延びる方向とほぼ同方向に沿って延びるように形成されている。そのため、保持部3では、注射器用取付部30に取り付けた注射器6の向き(注射器6の軸線が延びる方向)と、注射針2(注射針2の中心線が延びる方向)とが一致又は略一致するように構成されている。なお、図4においては、注射針2の中心線を「CL」で示している。   The through hole 310 is formed to extend along substantially the same direction as the direction in which the axis of the nozzle insertion portion 300 extends. Therefore, in the holding part 3, the direction of the syringe 6 attached to the syringe attachment part 30 (the direction in which the axis of the syringe 6 extends) and the injection needle 2 (the direction in which the center line of the injection needle 2 extends) match or substantially match. Is configured to do. In FIG. 4, the center line of the injection needle 2 is indicated by “CL”.

また、本実施形態では、前記高さ方向において、注射器用取付部30の中心から下方側にずれた位置に貫通孔310が形成されている。そのため、前記高さ方向においては、注射針2が、注射器用取付部30に取り付けた注射器6の中心(径方向における中心)よりも下方側に位置することになる。   In the present embodiment, the through-hole 310 is formed at a position shifted downward from the center of the syringe mounting portion 30 in the height direction. Therefore, in the height direction, the injection needle 2 is positioned below the center (the center in the radial direction) of the syringe 6 attached to the syringe attachment portion 30.

ベース部32は、図2に示すように、薄板状に形成されており、前記横幅方向における注射針用取付部31の両側に広がっている。   As shown in FIG. 2, the base portion 32 is formed in a thin plate shape and spreads on both sides of the injection needle attachment portion 31 in the lateral width direction.

本実施形態に係る保持部3では、ベース部32の先端面と注射針用取付部31の先端面とが連続しており、これにより、前記前後方向における後方側に凸となるように湾曲する一つの湾曲面33が形成されている。   In the holding portion 3 according to the present embodiment, the distal end surface of the base portion 32 and the distal end surface of the injection needle mounting portion 31 are continuous, and thereby bend so as to protrude rearward in the front-rear direction. One curved surface 33 is formed.

伸展部4は、注射針2の中心線を含む仮想平面上において、該中心線に沿って注射針2の先端から所定距離だけ前方に離れた位置(ずれた位置)に配置されている。そのため、伸展部4と注射針2の先端との間には空間が形成されている。   The extending portion 4 is disposed on a virtual plane including the center line of the injection needle 2 at a position (a position shifted) away from the tip of the injection needle 2 by a predetermined distance along the center line. Therefore, a space is formed between the extension portion 4 and the tip of the injection needle 2.

さらに、伸展部4は、図4に示すように、人体の皮膚(表皮の表面)に当接させる伸展面40と、該伸展面40から膨出する膨出部41とを有する。なお、図4においては、伸展面40が広がる平面を「P1」で示している。   Further, as shown in FIG. 4, the extended portion 4 has an extended surface 40 that comes into contact with the human skin (the surface of the epidermis) and a bulged portion 41 that bulges from the extended surface 40. In FIG. 4, the plane on which the extended surface 40 extends is indicated by “P1”.

伸展面40は、仮想平面に対する傾斜角度が注射針2の穿刺角度の最小角度から最大角度までの範囲内の角度に設定されている。伸展面40は、伸展部4の下面(前記高さ方向における下側の面)により構成されている。   The extending surface 40 has an inclination angle with respect to the virtual plane set to an angle within a range from a minimum angle to a maximum angle of the puncture angle of the injection needle 2. The extended surface 40 is configured by the lower surface of the extended portion 4 (the lower surface in the height direction).

なお、穿刺角度とは、注射針2の先端を真皮に到達させるうえで、好適な注射針2の傾きのことである。仮想平面に対する伸展面40の傾斜角度は、1°〜45°の範囲内で設定できるが、5°〜30°の範囲内で設定されていることが好ましく、5°〜15°の範囲内で設定されていることがより好ましい。なお、マントー法による皮内注射では、注射針2の穿刺角度が5°〜15°となるため、仮想平面に対する伸展面40の傾斜角度が5°〜15°の範囲内で設定されている場合は、注射針2をマントー法による皮内注射に適した角度に傾け易くなる。   The puncture angle is a preferable inclination of the injection needle 2 when the tip of the injection needle 2 reaches the dermis. The inclination angle of the extended surface 40 with respect to the virtual plane can be set within the range of 1 ° to 45 °, but is preferably set within the range of 5 ° to 30 °, and within the range of 5 ° to 15 °. More preferably, it is set. In addition, in the intradermal injection by the Manto method, the puncture angle of the injection needle 2 is 5 ° to 15 °, and therefore the inclination angle of the extension surface 40 with respect to the virtual plane is set within the range of 5 ° to 15 °. Makes it easier to tilt the injection needle 2 to an angle suitable for intradermal injection by the Manto method.

膨出部41は、伸展面40から下方側に向かって膨出している。なお、膨出部41の数は、複数であってもよいし、一つだけであってもよい。   The bulging portion 41 bulges downward from the extended surface 40. In addition, the number of the bulging parts 41 may be plural or only one.

図2に示すように、本実施形態の伸展部4は、前記横幅方向における中央部にスリット42が形成されており、前記横幅方向で二つに分断されている。そのため、伸展部4は、前記横幅方向で間隔をあけて並ぶ一対の押圧部43を有している。また、本実施形態では、伸展面40が、各押圧部43の下面(前記高さ方向における下面)により構成されている。   As shown in FIG. 2, the extension part 4 of this embodiment is formed with a slit 42 at the center in the lateral width direction and is divided into two in the lateral width direction. Therefore, the extension part 4 has a pair of pressing parts 43 arranged at intervals in the lateral width direction. Moreover, in this embodiment, the extended surface 40 is comprised by the lower surface (lower surface in the said height direction) of each press part 43. As shown in FIG.

接続アーム部5は、前記横幅方向で注射針2と並ぶ位置に形成されている。また、接続アーム部5と注射針2とは前記横幅方向で互いに間隔をあけて並んでいる。本実施形態では、かかる接続アーム部5が、前記横幅方向で注射針2の一方側と他方側とに個別に設けられている。なお、接続アーム部5は、注射針2と人体等との不用意な接触を防止するための保護部でもある。   The connection arm portion 5 is formed at a position aligned with the injection needle 2 in the lateral width direction. Further, the connecting arm portion 5 and the injection needle 2 are arranged at a distance from each other in the lateral width direction. In the present embodiment, such connection arm portions 5 are individually provided on one side and the other side of the injection needle 2 in the lateral width direction. The connection arm portion 5 is also a protection portion for preventing inadvertent contact between the injection needle 2 and a human body or the like.

各接続アーム部5の前記横幅方向における内側の側面(以下、内縁面と称する)50は、前記横幅方向における外側に凸となるように湾曲している。すなわち、各接続アーム部5の内縁面は、前記横幅方向において互いに相反する方向に向かって凸となるように湾曲している。   An inner side surface (hereinafter referred to as an inner edge surface) 50 in the lateral width direction of each connection arm portion 5 is curved so as to protrude outward in the lateral width direction. That is, the inner edge surface of each connection arm part 5 is curving so that it may become convex toward the mutually opposite direction in the said width direction.

各接続アーム部5の下面は、前記高さ方向における上方側に向かって凸となるように湾曲する逃面51となっている(図3参照)。   The lower surface of each connection arm portion 5 is a relief surface 51 that is curved so as to protrude upward in the height direction (see FIG. 3).

ここで、押圧部43について説明する。押圧部43は、図2に示すように、各接続アーム部5の先端に個々に設けられている。   Here, the pressing part 43 will be described. As shown in FIG. 2, the pressing portion 43 is individually provided at the tip of each connection arm portion 5.

各押圧部43は、接続アーム部5の先端から前記横幅方向における内側に向かって延出しており、各押圧部43の先端部は、前記横幅方向で間隔をあけて互いに対向している。   Each pressing portion 43 extends from the distal end of the connection arm portion 5 toward the inner side in the lateral width direction, and the distal end portions of the pressing portions 43 face each other with an interval in the lateral width direction.

各押圧部43の先端面430(前記前後方向における先端面)は、前記横幅方向に沿って真っすぐに形成されている。   The front end surface 430 (the front end surface in the front-rear direction) of each pressing portion 43 is formed straight along the lateral width direction.

一方、各押圧部43の後端面431(前記前後方向における後端面)は、前記横幅方向における内側に向かうにつれて徐々に前方に向かうように湾曲している。   On the other hand, the rear end surface 431 (the rear end surface in the front-rear direction) of each pressing portion 43 is curved to gradually move forward as it goes inward in the lateral width direction.

そして、本実施形態では、各押圧部43の後端面431、各接続アーム部5の内縁面、保持部3の湾曲面33が連続して一つの円弧状の曲面が形成されており、これにより、注射針2の先端部の周りには、該先端部を中心として円形状に広がる領域が形成されている。   In the present embodiment, the rear end surface 431 of each pressing portion 43, the inner edge surface of each connecting arm portion 5, and the curved surface 33 of the holding portion 3 are continuously formed into one arcuate curved surface. Around the distal end portion of the injection needle 2, a region that extends in a circular shape around the distal end portion is formed.

本実施形態に係る皮内注射用補助具1の構成は以上の通りである。続いて、皮内注射用補助具1の使い方について添付図面を参照しつつ説明を行う。なお、図5(a)に示すように、皮膚S1は皮下組織S2の上に重なっており、さらに、皮膚S1には、皮膚S1の外表面を構成する表皮S10と、表皮S10と皮下組織S2との間の真皮S11とが含まれている。   The configuration of the auxiliary tool 1 for intradermal injection according to the present embodiment is as described above. Next, how to use the auxiliary device 1 for intradermal injection will be described with reference to the accompanying drawings. As shown in FIG. 5A, the skin S1 is overlaid on the subcutaneous tissue S2. Further, the skin S1 includes an epidermis S10 that constitutes the outer surface of the skin S1, an epidermis S10, and the subcutaneous tissue S2. And dermis S11 in between.

まず、皮内注射用補助具1を注射器6に取り付ける。図4に示すように、注射器6がルアーロック部61を有するものである場合は、突出部301をルアーロック部61に螺合させつつ、ノズル60を注射器用取付部30の内部に圧入する。注射器用取付部30に取り付けられた注射器6の軸線方向と注射針2の中心線とは、同一又は略同一の方向に沿って延びている。   First, the intradermal injection aid 1 is attached to the syringe 6. As shown in FIG. 4, when the syringe 6 has the luer lock portion 61, the nozzle 60 is press-fitted into the syringe mounting portion 30 while the protruding portion 301 is screwed into the luer lock portion 61. The axial direction of the syringe 6 attached to the syringe attachment portion 30 and the center line of the injection needle 2 extend along the same or substantially the same direction.

続いて、図5(a)に示すように、伸展面40を皮膚S1(表皮S10)の表面に対して平行にして当接させる。伸展面40は、注射針2に対して穿刺角度の最小角度から最大角度までの範囲内の角度で傾いているため、該伸展面40を皮膚S1の表面に当接させると、注射針2が皮膚S1の表面に対して穿刺角度の最小角度から最大角度までの範囲内の角度で傾き、注射器6もまた、皮膚S1の表面に対して注射針2と同一の角度又は略同一の角度で傾く。   Subsequently, as shown in FIG. 5A, the extension surface 40 is brought into contact with the surface of the skin S1 (skin S10) in parallel. Since the extension surface 40 is inclined with respect to the injection needle 2 at an angle within the range from the minimum puncture angle to the maximum angle, when the extension surface 40 is brought into contact with the surface of the skin S1, the injection needle 2 The syringe 6 is also inclined with respect to the surface of the skin S1 at an angle within a range from the minimum angle to the maximum angle of the puncture angle, and the syringe 6 is also inclined with respect to the surface of the skin S1 at the same angle or substantially the same angle. .

伸展部4は、注射針2の先端から所定距離だけ離間するように配置されているため、伸展面40は、注射針2を穿刺する予定位置よりも前方の領域で皮膚S1に当接する。以下の説明において、皮膚S1のうち、伸展面40が当接する領域を押圧領域、注射針2を穿刺する予定位置を含む押圧領域の後ろ側の領域を後方領域と称する。   Since the extension part 4 is arranged so as to be separated from the tip of the injection needle 2 by a predetermined distance, the extension surface 40 contacts the skin S1 in a region in front of the position where the injection needle 2 is punctured. In the following description, in the skin S1, a region where the extension surface 40 abuts is referred to as a pressing region, and a region behind the pressing region including a planned position where the injection needle 2 is punctured is referred to as a rear region.

そして、皮膚S1に対して伸展面40がずれないようにしながら、注射針2の中心線が延びる方向に沿って注射器6ごと皮内注射用補助具1を前進させて伸展面40を皮膚S1に押し込む。   Then, while preventing the stretched surface 40 from shifting relative to the skin S1, the intradermal injection aid 1 is advanced along with the syringe 6 along the direction in which the center line of the injection needle 2 extends, so that the stretched surface 40 is brought into the skin S1. Push in.

このようにすると、図5(b)に示すように、押圧領域が凹むとともに、後方領域が前方に引き伸ばされる(伸展する)。また、後方領域は、押圧領域との境目となる位置が最も深く沈み込むが、押圧領域との境目よりも後ろ側の部分は、皮膚S1の弾力によって膨らむため、注射針2の穿刺進路上に該後方領域の一部がさしかかる。   If it does in this way, as shown in Drawing 5 (b), while a press field will be dented, a back field will be extended ahead (extend). In addition, the rear region sinks deepest at the boundary with the pressing region, but the portion behind the boundary with the pressing region swells due to the elasticity of the skin S1, so that it is on the puncture path of the injection needle 2. Part of the rear region is approaching.

そして、皮内注射用補助具1を移動させ続けると、注射針2が角度を保ったまま後方領域に刺さり、図6(a)に示すように、注射針2の先端部が表皮S10を貫いて真皮S11に到達する。この状態で注射器6内の注射液を注入すると、図6(b)に示すように、真皮S11が膨らんで膨隆部S12が形成される。   When the intradermal injection aid 1 is continuously moved, the injection needle 2 is stuck in the rear region while maintaining the angle, and the tip of the injection needle 2 penetrates the epidermis S10 as shown in FIG. 6 (a). To reach the dermis S11. When the injection solution in the syringe 6 is injected in this state, as shown in FIG. 6B, the dermis S11 swells to form a bulging portion S12.

そして、皮内注射用補助具1を後退させて皮膚S1から注射針2を引き抜き、皮内注射が完了する。   Then, the auxiliary tool 1 for intradermal injection is retracted and the injection needle 2 is pulled out from the skin S1, and the intradermal injection is completed.

以上のように、本実施形態に係る皮内注射用補助具1によれば、仮想平面(注射針2)に対する傾斜角度が前記穿刺角度の最小角度から最大角度までの範囲内の角度に設定されている伸展面40が、注射針2の中心線に沿う方向で、注射針2の先端から所定距離だけ離間した位置に配置されているため、伸展面40を皮膚S1に押し込みながら伸展部4を前方に移動させるだけで、注射針2の先端と伸展部4の間の皮膚S1が伸展されるとともに、注射針2が傾き(皮膚S1に対する傾き)を保ったまま皮膚S1に刺さる。   As described above, according to the intracutaneous injection assisting device 1 according to the present embodiment, the inclination angle with respect to the virtual plane (injection needle 2) is set to an angle within the range from the minimum angle to the maximum angle of the puncture angle. Since the extending surface 40 is arranged at a position away from the tip of the injection needle 2 by a predetermined distance in the direction along the center line of the injection needle 2, the extension portion 4 is pushed while pushing the extension surface 40 into the skin S1. By simply moving forward, the skin S1 between the tip of the injection needle 2 and the extension portion 4 is extended, and the injection needle 2 is stuck into the skin S1 while maintaining the inclination (inclination relative to the skin S1).

このように、上記構成の皮内注射用補助具1は、皮膚S1を伸展させる操作の流れの中で、注射針2を穿刺角度の最小角度から最大角度までの範囲内の角度で傾けたまま皮膚S1に刺すことができる。従って、皮内注射用補助具1は、皮内注射を行う際に皮膚S1に対して注射針2を容易且つ正確に穿刺できる、という優れた効果を奏し得る。   In this way, the intracutaneous injection assisting device 1 having the above-described configuration keeps the injection needle 2 tilted at an angle within the range from the minimum angle to the maximum angle of the puncture angle in the flow of the operation of extending the skin S1. The skin S1 can be stabbed. Therefore, the auxiliary device 1 for intradermal injection can exhibit an excellent effect that the injection needle 2 can be punctured easily and accurately into the skin S1 when performing intradermal injection.

また、伸展面40を皮膚S1の表面に当接させた時点で、注射針2の向きと、注射針2と伸展部4が並ぶ方向とが、皮膚S1に注射針2を刺す方向に揃うため、所定の一方向に皮内注射器補助具1を移動させるだけで(すなわち、皮内注射器補助具1を移動させる方向を変えずに)皮膚S1を伸展させ、該皮膚S1に対して注射針2を皮内注射に適した角度のまま刺すことができる。   Further, when the extension surface 40 is brought into contact with the surface of the skin S1, the direction of the injection needle 2 and the direction in which the injection needle 2 and the extension portion 4 are aligned are aligned with the direction in which the injection needle 2 is inserted into the skin S1. The skin S1 is extended only by moving the intradermal syringe auxiliary tool 1 in a predetermined direction (that is, without changing the direction in which the intradermal syringe auxiliary tool 1 is moved), and the injection needle 2 is applied to the skin S1. Can be stabbed at an angle suitable for intradermal injection.

なお、本実施形態では、伸展面40を皮膚S1の表面に当接させた時点で、注射器6の向きも皮膚S1に注射針2を刺す方向に揃うため、注射器6を手に持った状態で皮内注射用補助具1を動かして伸展部4を皮膚S1に押し込む際に、注射針2の姿勢を保ち易くすることができる。   In the present embodiment, when the extension surface 40 is brought into contact with the surface of the skin S1, the direction of the syringe 6 is aligned with the direction in which the injection needle 2 is inserted into the skin S1, so that the syringe 6 is held in the hand. When the intradermal injection aid 1 is moved and the extension portion 4 is pushed into the skin S1, the posture of the injection needle 2 can be easily maintained.

また、注射針2の前方には伸展部4が、注射針2の両隣り、より具体的には、仮想平面上で且つ前記横幅方向における前記注射針2の両側には一対の接続アーム部5(保護部)が設けられているため、注射針2の周囲が伸展部4と一対の接続アーム部5とによって囲まれ、注射針2が不用意に人体等に接触してしまうことを抑制でき、また、注射針2が誤った姿勢で皮膚S1に刺さってしまうことを防止できる。   Further, an extension portion 4 is provided in front of the injection needle 2, and a pair of connection arm portions 5 are provided on both sides of the injection needle 2, more specifically, on a virtual plane and on both sides of the injection needle 2 in the lateral width direction. Since the (protection part) is provided, the periphery of the injection needle 2 is surrounded by the extension part 4 and the pair of connection arm parts 5, and the injection needle 2 can be prevented from inadvertently contacting a human body or the like. Moreover, it is possible to prevent the injection needle 2 from being stuck in the skin S1 in an incorrect posture.

さらに、注射針2と接続アーム部5との間には、スペースが形成されているため、真皮S11に注射液を注入した際に、膨隆部S12の形成、すなわち、真皮S11への注射液の注入が妨げられにくくなる。   Further, since a space is formed between the injection needle 2 and the connection arm portion 5, when the injection solution is injected into the dermis S11, formation of the bulging portion S12, that is, the injection solution to the dermis S11 is formed. Injection is less likely to be hindered.

また、接続アーム部5の下面は、上方側に向かって凸状に湾曲する逃面51となっているため、該接続アーム部5の下面によって皮膚が圧迫されにくくなり、真皮S11に注射液を注入する際に膨隆部S12の形成を阻害しないようにすることができる(すなわち、真皮S11への注射液の注入を阻害しないようにすることができる)。   Further, since the lower surface of the connection arm portion 5 is a relief surface 51 that is convexly curved upward, the skin is less likely to be pressed by the lower surface of the connection arm portion 5, and an injection solution is injected into the dermis S11. It is possible to prevent the formation of the bulging portion S12 during the injection (that is, it is possible to prevent the injection solution from being injected into the dermis S11).

なお、本発明の皮内注射用補助具は、上記実施形態に限定されるものではなく、本発明の要旨を逸脱しない範囲内において種々の変更を加え得ることは勿論である。   In addition, the auxiliary tool for intradermal injection of this invention is not limited to the said embodiment, Of course, a various change can be added in the range which does not deviate from the summary of this invention.

上記実施形態では特に言及していなかったが、保持部3の先端側の下面(本実施形態では、注射針用取付部31の下面とベース部32の下面とで構成される一面)は、仮想平面に対する傾斜角度が前記穿刺角度の最小角度となるように形成されていてもよい。   Although not particularly mentioned in the above embodiment, the lower surface on the distal end side of the holding portion 3 (in this embodiment, one surface composed of the lower surface of the injection needle mounting portion 31 and the lower surface of the base portion 32) is assumed to be virtual. The inclination angle with respect to the plane may be formed to be the minimum angle of the puncture angle.

上記実施形態では、注射器用取付部30を、ルアーロック部61を有する注射器6に取り付けることを前提にして説明したが、ルアーロック部61を持たない注射器6に取り付けることも可能である。   In the above-described embodiment, the syringe mounting portion 30 has been described on the assumption that the syringe mounting portion 30 is mounted on the syringe 6 having the luer lock portion 61. However, the syringe mounting portion 30 may be mounted on the syringe 6 that does not have the luer lock portion 61.

上記実施形態において、注射器用取付部30は、ルアーロック部61に螺合させる突出部301を有するように構成されていたが、この構成に限定されない。例えば、注射器用取付部30には突出部301が設けられていなくてもよい。なお、突出部301を持たない注射器用取付部30であっても、ルアーロック部61を有する注射器6のノズルに対して該注射器用取付部30の注射器用取付部30を圧入することは可能である。   In the above-described embodiment, the syringe attachment portion 30 is configured to have the protruding portion 301 that is screwed into the luer lock portion 61, but is not limited to this configuration. For example, the protruding portion 301 may not be provided on the syringe mounting portion 30. In addition, even if it is the syringe attachment part 30 which does not have the protrusion part 301, it is possible to press-fit the syringe attachment part 30 of this syringe attachment part 30 with respect to the nozzle of the syringe 6 which has the luer lock part 61. is there.

上記実施形態において、注射針用取付部31の貫通孔310は、注射器用取付部30の径方向における中心よりも下方側にずれた位置に形成されていたが、この構成に限定されない。例えば、注射針用取付部31の貫通孔310は、注射器用取付部30の径方向における中心を通って軸線方向(注射器用取付部30の軸線方向)に延びる直線上に形成されていてもよい。但し、注射器用取付部30の径方向における中心よりも下方側にずれた位置に貫通孔310が形成されている方が、伸展面40を皮膚に当接させた際に注射針2を皮膚の近くに配置できるため、皮内注射を行い易くなる。   In the above embodiment, the through-hole 310 of the injection needle attachment portion 31 is formed at a position shifted downward from the center of the syringe attachment portion 30 in the radial direction, but is not limited to this configuration. For example, the through hole 310 of the injection needle attachment portion 31 may be formed on a straight line that extends in the axial direction (the axial direction of the injection attachment portion 30) through the center of the syringe attachment portion 30 in the radial direction. . However, when the through-hole 310 is formed at a position shifted downward from the center in the radial direction of the syringe attachment portion 30, the injection needle 2 is attached to the skin when the extension surface 40 is brought into contact with the skin. Intradermal injection is facilitated because it can be placed nearby.

上記実施形態において特に言及しなかったが、伸展部4のスリット42の幅は、皮膚の後方領域を伸展させることができる範囲内で設定されていればよい。   Although not specifically mentioned in the above embodiment, the width of the slit 42 of the extension portion 4 only needs to be set within a range in which the rear region of the skin can be extended.

上記実施形態において、伸展部4は、前記横幅方向で二つに分断されていたが、分断されることが必ずしも必要となるものではない。   In the said embodiment, although the extension part 4 was divided into two by the said horizontal width direction, it is not necessarily required to be divided.

上記実施形態において特に言及しなかったが、図7、及び図8に示すように、保持部3の先端部側の下面(具体的には、注射針用取付部31の下面とベース部32の下面とで構成される一面)には、前記保持部3の後端部側の下面よりも下方側に膨出する深刺抑制部34が形成されていてもよい。   Although not particularly mentioned in the above embodiment, as shown in FIG. 7 and FIG. 8, the lower surface of the holding portion 3 on the distal end side (specifically, the lower surface of the injection needle mounting portion 31 and the base portion 32). On one surface composed of the lower surface, a deep puncture suppressing portion 34 that bulges downward from the lower surface on the rear end side of the holding portion 3 may be formed.

かかる構成によれば、保持部3の先端部側の下面には、後端部側の下面よりも下方側に膨出する深刺抑制部34が形成されるため、伸展面40を皮膚S1に押し込む際に、該深刺抑制部34が皮膚S1に当接したことを目安にして伸展面40を押し込む操作、すなわち、皮膚S1に注射針2を刺し込む操作を止めることができる。従って、上記構成の皮内注射用補助具1は、注射針2が皮膚S1に対して過剰に刺し込まれてしまうことを抑制できる。   According to this configuration, since the deep puncture suppressing portion 34 that bulges downward from the lower surface on the rear end portion side is formed on the lower surface on the front end portion side of the holding portion 3, the extension surface 40 is formed on the skin S1. When pushing, the operation of pushing the extension surface 40, that is, the operation of putting the injection needle 2 into the skin S1, can be stopped based on the fact that the deep puncture suppressing portion 34 is in contact with the skin S1. Therefore, the auxiliary device for intradermal injection 1 having the above-described configuration can suppress the injection needle 2 from being excessively inserted into the skin S1.

また、前記深刺抑制部34の下面には、仮想平面に対する傾斜角度が前記注射針の穿刺角度の最小角度から最大角度までの範囲内の角度に設定される角度制限面340が含まれていてもよい。なお、図8においては、注射針2の中心線を「CL」、伸展面40が広がる平面を「P1」、角度制限面340が広がる平面を「P2」で示している。   Further, the lower surface of the deep puncture suppressing unit 34 includes an angle limiting surface 340 in which an inclination angle with respect to a virtual plane is set to an angle within a range from a minimum angle to a maximum angle of the puncture angle of the injection needle. Also good. In FIG. 8, the center line of the injection needle 2 is indicated by “CL”, the plane on which the extension surface 40 extends is indicated by “P1”, and the plane on which the angle limiting surface 340 extends is indicated by “P2”.

かかる構成によれば、誤って伸展部4を皮膚S1に当接させずに注射針2を皮膚S1に穿刺してしまった場合であっても、保持部3の外底部に形成された角度制限面340が皮膚S1に当接すれば、注射針2が穿刺角度の最小角度から最大角度までの範囲内の角度で傾くため、使用手順を誤った場合であっても、注射針2の穿刺角度が許容範囲を超えてしまうことを抑制できる。   According to such a configuration, even if the injection needle 2 is punctured into the skin S1 without causing the extension portion 4 to contact the skin S1, the angle limit formed on the outer bottom portion of the holding portion 3 is limited. If the surface 340 comes into contact with the skin S1, the injection needle 2 tilts at an angle within the range from the minimum angle to the maximum angle of the puncture angle. Exceeding the allowable range can be suppressed.

なお、図9、図10に示すように、前記深刺抑制部34の下面を注射針2の中心線が延びる方向に一致又は略一致させることも可能であり、この場合は、注射針2が皮膚S1に対して過剰に刺し込まれてしまうことを抑制できる効果が高まる。   As shown in FIGS. 9 and 10, it is possible to make the lower surface of the deep puncture suppressing portion 34 coincide with or substantially coincide with the direction in which the center line of the injection needle 2 extends. The effect which can suppress that it stabs excessively with respect to skin S1 increases.

1…皮内注射用補助具、2…注射針、3…保持部、4…伸展部、5…接続アーム部、6…注射器、30…注射器用取付部、31…注射針用取付部、32…ベース部、33…湾曲面、34…深刺抑制部、40…伸展面、41…膨出部、42…スリット、43…押圧部、50…内縁面、51…逃面、60…ノズル、61…ルアーロック部、300…ノズル挿入部、301…突出部、310…貫通孔、340…角度制限面、S1…皮膚、S10…表皮、S11…真皮、S12…膨隆部、S2…皮下組織 DESCRIPTION OF SYMBOLS 1 ... Intradermal injection aid, 2 ... Injection needle, 3 ... Holding part, 4 ... Extension part, 5 ... Connection arm part, 6 ... Syringe, 30 ... Syringe attachment part, 31 ... Injection needle attachment part, 32 DESCRIPTION OF SYMBOLS ... Base part, 33 ... Curved surface, 34 ... Deep penetration suppression part, 40 ... Extension surface, 41 ... Swelling part, 42 ... Slit, 43 ... Press part, 50 ... Inner edge surface, 51 ... Relief surface, 60 ... Nozzle, 61 ... Luer lock part, 300 ... Nozzle insertion part, 301 ... Projection part, 310 ... Through hole, 340 ... Angle limiting surface, S1 ... Skin, S10 ... Epidermis, S11 ... Dermis, S12 ... Swelling part, S2 ... Subcutaneous tissue

Claims (6)

注射針を保持する保持部と、
皮膚の表面に押し付けて皮膚を伸展させる伸展部であって、前記注射針の中心線を含み且つ横幅方向に広がる仮想平面上において、該中心線に沿う方向で前記注射針の先端から所定距離だけ離間した位置に配置される伸展部と、を備え、
前記伸展部は、前記仮想平面に対する傾斜角度が前記注射針の穿刺角度の最小角度から最大角度までの範囲内の角度に設定される伸展面を有する、
皮内注射用補助具。
A holding part for holding the injection needle;
An extension part that presses against the surface of the skin and extends the skin, and includes a center line of the injection needle and extends in a lateral width direction, and extends a predetermined distance from the tip of the injection needle in a direction along the center line. An extending portion disposed at a spaced position;
The extension portion has an extension surface in which an inclination angle with respect to the virtual plane is set to an angle within a range from a minimum angle to a maximum angle of the puncture angle of the injection needle.
Auxiliary device for intradermal injection.
前記仮想平面上であり且つ前記横幅方向における前記注射針の両側に配置される一対の保護部を備える、
請求項1に記載の皮内注射用補助具。
A pair of protection parts disposed on both sides of the injection needle on the virtual plane and in the lateral width direction;
The auxiliary tool for intradermal injection according to claim 1.
前記保護部は、前記横幅方向で前記注射針との間に間隔をあけて配置される、
請求項2に記載の皮内注射用補助具。
The protective part is arranged with a space between the injection needle in the lateral width direction,
The auxiliary tool for intradermal injection according to claim 2.
前記保持部の先端部側の下面には、前記保持部の後端部側の下面よりも下方側に膨出する深刺抑制部が形成される、
請求項1乃至請求項3の何れか1項に記載の皮内注射用補助具。
On the lower surface on the distal end side of the holding portion, a deep puncture suppressing portion that bulges downward from the lower surface on the rear end portion side of the holding portion is formed.
The auxiliary device for intradermal injection according to any one of claims 1 to 3.
前記深刺抑制部の下面には、前記仮想平面に対する傾斜角度が前記注射針の穿刺角度の最小角度から最大角度までの範囲内の角度に設定される角度制限面が含まれる、
請求項4に記載の皮内注射用補助具。
The lower surface of the deep puncture suppressing portion includes an angle limiting surface in which an inclination angle with respect to the virtual plane is set to an angle within a range from a minimum angle to a maximum angle of the puncture angle of the injection needle.
The auxiliary tool for intradermal injection according to claim 4.
前記保護部の下面は、上方側に向かって凸状に湾曲する逃面となっている、
請求項2又は請求項3に記載の皮内注射用補助具。
The lower surface of the protective portion is a relief surface that curves in a convex shape toward the upper side,
The auxiliary tool for intradermal injection according to claim 2 or 3.
JP2018103795A 2018-05-30 2018-05-30 Intracutaneous injection aid Pending JP2019205792A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018103795A JP2019205792A (en) 2018-05-30 2018-05-30 Intracutaneous injection aid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018103795A JP2019205792A (en) 2018-05-30 2018-05-30 Intracutaneous injection aid

Publications (1)

Publication Number Publication Date
JP2019205792A true JP2019205792A (en) 2019-12-05

Family

ID=68766934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018103795A Pending JP2019205792A (en) 2018-05-30 2018-05-30 Intracutaneous injection aid

Country Status (1)

Country Link
JP (1) JP2019205792A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3324854A (en) * 1964-04-23 1967-06-13 Harry Swartz Apparatus for facilitating the insertion of a hypodermic syringe needle
US20060129123A1 (en) * 2000-12-19 2006-06-15 Steven Wojcik Transcutaneous inserter for low-profile infusion sets
JP2010524646A (en) * 2007-04-23 2010-07-22 エス・アイ・ディ・テクノロジーズ・リミテッド・ライアビリティ・カンパニー Method and apparatus for intradermal injection
JP2014069084A (en) * 2012-09-27 2014-04-21 Becton Dickinson & Co Angled inserter for drug infusion

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3324854A (en) * 1964-04-23 1967-06-13 Harry Swartz Apparatus for facilitating the insertion of a hypodermic syringe needle
US20060129123A1 (en) * 2000-12-19 2006-06-15 Steven Wojcik Transcutaneous inserter for low-profile infusion sets
JP2010524646A (en) * 2007-04-23 2010-07-22 エス・アイ・ディ・テクノロジーズ・リミテッド・ライアビリティ・カンパニー Method and apparatus for intradermal injection
JP2014069084A (en) * 2012-09-27 2014-04-21 Becton Dickinson & Co Angled inserter for drug infusion

Similar Documents

Publication Publication Date Title
JP3204337U (en) Indwelling needle with prevention of puncture
JP2006517441A (en) Optimally sharpened needle to reduce force for insertion
CN104771807A (en) Safety needle devices and related methods
JP6566160B1 (en) Indwelling needle assembly
JP2018532513A5 (en)
MX2012014150A (en) Indwelling needle device.
JP2020529887A (en) Methods and devices for introducing needles for catheter placement
JPWO2017073658A1 (en) Grip and syringe assembly
WO2014108027A1 (en) Safe venous indwelling needle
JP5905968B2 (en) Syringe
JP2011250999A (en) Puncture needle and blood vessel surface incisura formation instrument
KR101637803B1 (en) Epidural space identification device
JP2019205792A (en) Intracutaneous injection aid
JP7082732B2 (en) Injection device set
JP5996862B2 (en) Microneedle array and microneedle array device
JP2019198552A (en) Indwelling needle device
JP7100875B2 (en) Auxiliary tool for intradermal injection
JP5999415B2 (en) Indwelling needle device
JP6155437B2 (en) Puncture tool
CN216148163U (en) Ultrasonic guide nerve blocking needle
JPWO2014208507A1 (en) Intraocular lens insertion device
CN113598911A (en) Ultrasonic guide nerve blocking needle
KR20220103726A (en) Devices and systems to reduce premature needle lock activation
CN112704550A (en) PICC (peripherally inserted Central catheter) catheter placement instrument and catheter placement method
JP2023504325A (en) Intravenous catheter device

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210521

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220128

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220329

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220819

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221018

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230605

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230613

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230630